Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on October 11, 2022. The filing serves to distribute a press release dated October 11, 2022, as Exhibit 99.1. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, no data is available regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The nature of the update is limited to the distribution of the referenced press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. These elements would be contained within the attached press release (Exhibit 99.1), which is not included in the input.
Key Facts for Investor Verification
- The filing is a procedural submission to distribute a press release dated October 11, 2022.
- Financial performance metrics and strategic updates are not present in the cover document.
- Investors must review the full text of Exhibit 99.1 (the press release) to understand the specific corporate announcement.
- The report was signed by André Choulika, Chief Executive Officer.